| Literature DB >> 31142044 |
Karina M Vermeulen1, Márcia Marília G D Lopes2, Camila X Alves3, Naira J N Brito4, Maria das Graças Almeida5, Lucia Leite-Lais6, Sancha Helena L Vale7, José Brandão-Neto8.
Abstract
The parameters derived from bioelectrical impedance, phase angle (PA) and bioelectrical impedance vector analysis (BIVA) have been associated with cell membrane integrity and body cell mass. Zinc is a micronutrient that exerts important structural functions and acts in maintaining cellular functionality. To evaluate cell integrity and body cell mass, PA and BIVA were evaluated in children orally supplemented with zinc at different concentrations. Anthropometric, bioelectrical (resistance and reactance) and serum zinc variables were collected from two randomized, triple-blind, controlled clinical trials. Sampling was composed of 71 children consisting of three groups: a control group who received a placebo and two experimental groups who received oral supplementation of 5 or 10 mg-Zn/day for three months. The three groups presented increases (p < 0.001) in the linear height and weight. In the group supplemented with 10 mg-Zn/day, there was an increase in reactance values (p = 0.036) and PA (p = 0.002), in addition to vector displacement (p < 0.001) in relation to the confidence ellipses. An increase in serum zinc concentration was found (p < 0.001) in all three groups. Whit this, the supplementation with 10 mg-Zn/day promotes changes in the integrity of the cell membrane associated with the increase in the cellular mass of healthy children.Entities:
Keywords: Body composition; bioimpedance; cell membrane
Mesh:
Substances:
Year: 2019 PMID: 31142044 PMCID: PMC6627540 DOI: 10.3390/nu11061215
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Recruitment flowchart with inclusion and exclusion procedures.
Group characterization before oral zinc supplementation with different concentrations (CG = placebo; G1 = 5 mg-Zn/day; G2 = 10 mg-Zn/day).
| Group | CG | G1 | G2 |
|
|---|---|---|---|---|
| n | 24 | 24 | 23 | -- |
| Age (years) | 8.4 (0.5) | 8.1 (1.0) | 9.1 (0.5) | <0.001 |
| Serum zinc (μg/mL) | 0.92 (0.13) | 1.01 (0.12) | 0.90 (0.11) | 0.007 |
| WAZ | −0.15 (0.79) | −0.85 (0.82) | −0.43 (1.05) | 0.031 |
| HAZ | 0.26 (0.98) | −0.64 (0.82) | −0.39 (1.19) | 0.008 |
| BAZ | −0.47 (0.74) | −0.70 (0.68) | −0.27 (0.75) | 0.142 |
| Resistance (Ω) | 773 (41) | 807 (65) | 748 (91) | 0.017 |
| R/H (Ω/cm) | 590.1 (41.7) | 654.4 (73.3) | 576.0 (87.8) | 0.001 |
| Reactance (Ω) | 71 (8) | 75 (9) | 68 (6) | 0.008 |
| Xc/H (Ω/cm) | 54.3 (7.2) | 60.8 (7.9) | 52.2 (6.4) | <0.001 |
| Phase angle (°) | 5.28 (0.68) | 5.34 (0.61) | 5.25 (0.64) | 0.879 |
| FFM (%) | 79.8 (2.8) | 78.7 (4.2) | 78.8 (3.7) | 0.524 |
WAZ, weight-for-age Z-score; HAZ, height-for-age Z-score; BAZ, Body mass index-for-age Z-score; R/H, Resistance/Height; Xc, Reactance/Height; FFM, fat-free mass. Continuous variables are presented as the means (standard deviations). 1 One-way ANOVA.
Figure 2Intragroup comparison of serum zinc before (T0) and after (T1) three months of intervention with different oral supplementation of zinc in eutrophic children.
Anthropometric characteristics and bioelectric parameters before and after oral supplementation with different concentrations of zinc.
| Control Group | Group 1 | Group 2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Anthropometrics | Before | After |
| Before | After |
| Before | After |
|
| Weight (Kg) | 27.4 | 27.2 | <0.001 | 22.8 (3.4) | 23.4 | <0.001 | 27.1 | 28.0 | <0.001 |
| Height (cm) | 131.2 | 132.6 | <0.001 | 123.8 | 125.1 | <0.001 | 130.6 | 132.1 | <0.001 |
| BMI (Kg/m²) | 15.3 | 15.4 | 0.141 | 14.8 | 14.9 | 0.334 | 15.8 | 15.9 | 0.053 |
| WAZ | −0.15 | −0.15 | 0.980 | −0.85 | −0.85 | 0.938 | −0.47 | −0.43 | 0.152 |
| HAZ | 0.26 | 0.24 | 0.339 | −0.64 | −0.65 | 0.574 | −0.39 | −0.37 | 0.316 |
| BAZ | −0.47 | −0.46 | 0.809 | −0.70 | −0.69 | 0.970 | −0.27 | −0.24 | 0.500 |
|
|
|
|
|
|
|
|
|
|
|
| R (Ω) | 772.8 | 777.7 (50.7) | 0.559 | 806.7 | 800.0 (71.6) | 0.370 | 748.3 | 747.2 | 0.835 |
| R/H (Ω/cm) | 590.1 | 588.3 | 0.782 | 654.4 | 642.9 | 0.079 | 576.0 | 568.6 | 0.089 |
| Xc (Ω) | 71.0 | 71.9 | 0.579 | 75.0 | 75.0 | 0.955 | 67.9 | 70.0 | 0.036 |
| Xc/H (Ω/cm) | 54.3 (7.2) | 54.5 | 0.863 | 60.8 (7.9) | 60.3 | 0.737 | 52.2 (6.4) | 53.3 | 0.163 |
| PA (Ω) | 5.28 | 5.30 | 0.882 | 5.34 | 5.40 | 0.537 | 5.25 | 5.43 | 0.002 |
| FFM (%) | 79.8 | 79.2 | 0.065 | 78.7 | 78.9 | 0.478 | 78.8 | 78.7 | 0.558 |
WAZ, weight-for-age Z-score; HAZ, height-for-age Z-score; BAZ, Body mass index-for-age Z-score; R, resistance; Xc, reactance; H, height; FFM, Fat-free mass. Variables are presented as mean (standard deviation). ¹ Student’s t-test.
Figure 3Confidence ellipses of 95% of impedance vectors measured before (T0) and after (T1) three months of intervention with oral supplementation with different concentrations of zinc in eutrophic children. Black ellipse = control group; Green ellipse = Group 1; Red ellipse = Group 2. An upward or downward displacement of the main axis is associated with more or less soft tissue cell mass, respectively.